Understanding and treating Hajdu Cheney Syndrome
Mechanisms and Treatment of Hajdu Cheney Syndrome
This study is looking into Hajdu Cheney Syndrome, a condition that causes serious bone loss and fractures, to understand how a specific gene mutation affects bone health, and it aims to find new treatments that could help improve bone strength for those living with this condition.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Connecticut Sch of Med/dnt NIH-funded |
| Lab location | 1 site (Farmington, United States) |
| Project ID | NIH-11076693 on NIH RePORTER |
What this research studies
This research investigates Hajdu Cheney Syndrome (HCS), a genetic disorder that leads to severe bone loss and fractures. The study focuses on the role of Notch receptors in bone remodeling and how mutations in the NOTCH2 gene contribute to the disease. Using a mouse model, researchers will explore the mechanisms behind bone loss and develop targeted treatments using antisense oligonucleotides to correct the underlying genetic mutation. Patients may benefit from new therapeutic strategies aimed at improving bone health and reducing fractures.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Hajdu Cheney Syndrome or those exhibiting symptoms related to the condition.
Not a fit: Patients without Hajdu Cheney Syndrome or those with unrelated bone disorders may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to innovative treatments that significantly improve bone health and quality of life for patients with Hajdu Cheney Syndrome.
How similar studies have performed: Previous research has shown promise in using antisense oligonucleotides for genetic disorders, indicating potential success for this novel approach.
Where this research is happening
Farmington, United States
- University of Connecticut Sch of Med/dnt — Farmington, United States (Active)
Researchers
- Principal investigator: Canalis, Ernesto — University of Connecticut Sch of Med/dnt
- Study coordinator: Canalis, Ernesto
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.